Activation of the Stress Axis and Neurochemical Alterations in Specific Brain Areas by Concentrated Ambient Particle Exposure with Concomitant Allergic Airway Disease by Sirivelu, Madhu P. et al.
870 VOLUME 114 | NUMBER 6 | June 2006 • Environmental Health Perspectives
Research
In the past decade, numerous studies have
indicated a causal association between ambient
particulate matter (PM) in major metropolitan
areas and potential health risks (Pope 2004).
Daily death rate and hospital admissions due to
pulmonary and cardiovascular problems have
been shown consistently to parallel elevated
PM air pollution in several epidemiologic
reports (Brook 2005; Pope 2004; Samet et al.
2000; Schwartz 1999; von Klot et al. 2005).
Exposure to PM with an aerodynamic
diameter ≤ 2.5 µm (PM2.5) has been associated
with the incidence of respiratory conditions
(Johnson and Graham 2005; Peel et al. 2005).
Studies in various parts of the world have
linked PM exposure to allergic airway diseases
such as asthma (Barnett et al. 2005; D’Amato
et al. 2005; Kappos et al. 2004; Trasande and
Thurston 2005). PM exposure is known to
cause acute respiratory events such as acute
asthma exacerbations that are reflected as an
increase in the symptom score as well as an
increase in hospitalization and use of medica-
tion (Penttinen et al. 2001; von Klot et al.
2005). These responses are especially prevalent
in populations with preexisting pulmonary 
disorders such as chronic bronchitis and
chronic obstructive pulmonary diseases (Clarke
et al. 1999). Although coarse PM (≤ 10 µm;
PM10) can penetrate the human larynx and is
deposited in the trachea and larger airways,
ﬁner PM2.5 is believed to be more toxic because
of its large surface area and ease of accumula-
tion in the alveoli of the lungs (Lippmann et al.
2005). The composition of PM is also believed
to play a role in inﬂammatory reactions. Trace
elements of anthropogenic origin such as lan-
thanum, vanadium, manganese, and sulfur
(Morishita et al. 2004), nitric oxide (Barnett
et al. 2005), tobacco smoke (Tatum and
Shapiro 2005), and elemental or organic car-
bon from vehicle emissions (Lippmann et al.
2005; Peel et al. 2005) are all known to pro-
mote various respiratory conditions.
Although the substances associated with
PM can cause inﬂammation on their own, the
presence of PM2.5 in respiratory tissue can incite
inﬂammatory reactions as well. Inhalation of
PM2.5 results in its accumulation in the deeper
portions of the lungs where it may stimulate
macrophages and epithelial cells or cause an
inﬂux of neutrophils and eosinophils and pro-
mote cytokine and chemokine release (Tao
et al. 2003). This may increase the permeability
of the airways, and PM may enter the intersti-
tial space where it could elicit an allergen-
induced response (D’Amato et al. 2005). This
would result in an increase in T-helper 2 cell
(TH2) cytokines such as interleukin (IL)-4 and
IL-13 that play an important role in the patho-
physiology of allergic asthma (Marshall 2004).
Stress could be another important factor
that promotes asthma. High levels of psycho-
social stress are known to predict the onset of
asthma and are correlated with high asthma
morbidity (Sandberg et al. 2000). The eleva-
tion of stress hormones such as glucocorticoids
is known not only to suppress the immune sys-
tem but also to induce a shift in the TH1/TH2
cytokine balance toward a TH2 cytokine
response, which favors the onset of asthma
and allergic diseases (Marshall and Agarwal
2000). However, the effect of PM on the
stress axis has not been investigated before.
We hypothesized that exposure to PM2.5
can cause an activation of the stress axis and
that this effect would be more pronounced in
animals that have existing allergic airway dis-
ease. This could be mediated through neuro-
transmitters such as norepinephrine (NE) and
dopamine (DA) that are crucial for the stimu-
lation of the stress axis. To test this hypothesis,
we used an ovalbumin (OVA)-induced asthma
model and exposed these animals to concen-
trated air particles (CAPs) containing PM2.5.
The activation of the stress axis in these ani-
mals was measured by examining neurotrans-
mitter levels in different areas of the brain
related to neuroendocrine functions and by
correlating them with serum corticosterone.
Materials and Methods
Adult male Brown Norway (BN) rats
12–13 weeks old were obtained from Harlan
Sprague-Dawley (Indianapolis, IN) and
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OBJECTIVE: Exposure to ambient particulate matter (PM) has been linked to respiratory diseases in
people living in urban communities. The mechanism by which PM produces these diseases is not
clear. We hypothesized that PM could act on the brain directly to stimulate the stress axis and pre-
dispose individuals to these diseases. The purpose of this study was to test if exposure to PM can
affect brain areas involved in the regulation of neuroendocrine functions, especially the stress axis, and
to study whether the presence of preexisting allergic airway disease aggravates the stress response. 
DESIGN: Adult male rats (n = 8/group) with or without ovalbumin (OVA)-induced allergic airway
disease were exposed to concentrated air particles containing PM with an aerodynamic diameter
≤ 2.5 µm (PM2.5) for 8 hr, generated from ambient air in an urban Grand Rapids, Michigan, commu-
nity using a mobile air research laboratory (AirCARE 1). Control animals were exposed to normal air
and were treated with saline. 
MEASUREMENTS: A day after PM2.5 exposure, animals were sacriﬁced and the brains were removed,
frozen, and sectioned. The paraventricular nucleus (PVN) and other brain nuclei were micro-
dissected, and the concentrations of aminergic neurotransmitters and their metabolites were meas-
ured using high-performance liquid chromatography with electrochemical detection. Serum
corticosterone levels were measured using radioimmunoassay. 
RESULTS: A signiﬁcant increase in the concentration (mean ± SE, pg/µg protein) of norepinephrine
in the PVN was produced by exposure to concentrated ambient particles (CAPs) or OVA alone
(12.45 ± 2.7 and 15.84 ± 2.8, respectively) or after sensitization with OVA (19.06 ± 3.8) compared
with controls (7.98 ± 1.3; p < 0.05). Serum corticosterone (mean ± SE, ng/mL) was signiﬁcantly
elevated in the OVA + CAPs group (242.786 ± 33.315) and in the OVA-presensitized group
(242.786 ± 33.315) compared with CAP exposure alone (114.55 ± 20.9). Exposure to CAPs (alone
or in combination with OVA pretreatment) can activate the stress axis, and this could probably play
a role in aggravating allergic airway disease. 
KEY WORDS: CAPs, corticosterone, hypothalamus, norepinephrine, stress axis. Environ Health
Perspect 114:870–874 (2006). doi:10.1289/ehp.8619 available via http://dx.doi.org/ [Online
23 January 2006]divided into two groups (n = 16). We sensi-
tized one group to OVA by intranasally instill-
ing a 0.5% solution of OVA in saline
(150 µL/nasal passage) for 3 consecutive days.
Control animals received saline intranasally.
The airway sensitization of these animals was
conducted in J.R.H.’s laboratory at Michigan
State University. Fourteen days after the last
intranasal instillation, all the rats were moved
to the mobile air research laboratory
(AirCARE 1; Sioutas et al. 1997) located at
Calvin College (Grand Rapids, Michigan).
Approximately 1 hr before the start of the
inhalation exposure, rats were intranasally
instilled with a 1.0% solution of OVA in saline
(150 µL/nasal passage for antigen challenge) or
with saline alone (controls; no antigen chal-
lenge). Rats were further divided into two
groups (n = 8), placed in whole-body exposure
chambers, and exposed to fine CAPs drawn
from the local urban atmosphere or to ﬁltered
air drawn from room air (ﬁltered air controls).
We used a Harvard/U.S. Environmental
Protection Agency ambient ﬁne particle con-
centrator to generate the CAP exposures. The
concentration of PM2.5 in the CAP mixture
was 500 µg/m3. Animals were exposed to
CAPs for 8 hr. Twenty-four hours after expo-
sure, they were sacriﬁced by excess pentobarbi-
tal administration. The protocols were
approved by the Institutional Animal Care and
Use Committee at Michigan State University,
and experiments were performed according to
National Institutes of Health guidelines
(National Institutes of Health 2002).
Brain microdissection. At the time of sacri-
fice, the brain along with the olfactory bulb
was quickly removed and frozen on dry ice.
Serial coronal sections (300 µm thick) of the
brain were obtained using a cryostat (Slee
Mainz, London, UK) maintained at –10°C.
The sections were transferred to precleaned
microscopic slides placed on a cold stage at
–10°C. Various nuclei of the hypothalamus
including the paraventricular nucleus (PVN),
medial preoptic area (MPA), arcuate nucleus
(AN), median eminence, suprachiasmatic
nucleus (SCN), and the substantia nigra (SN)
were microdissected by the Palkovits’s microp-
unch technique (MohanKumar et al. 1998;
Palkovits 1973) using a 500-µm-diameter
punch with the rat brain stereotaxic atlas
(Paxinos and Watson 1987) as a reference.
Tissue samples were obtained bilaterally, and
all the subdivisions of the nuclei were included.
They were stored at –70°C until analysis for
neurotransmitter concentrations using high-
performance liquid chromatography with
electrochemical detection (HPLC-EC).
Neurotransmitter analysis. At the time of
analysis, tissue samples were homogenized in
150 µL of 0.1 M HCLO4, and an aliquot of
10 µL was saved for protein analysis. The
remaining sample was centrifuged briefly at
10,000×g, and 75 µL of the supernatant with
25 µL of internal standard (0.05 M dihydroxy
benzyl amine; Sigma Chemical Co., St. Louis,
MO) was injected into the HPLC system. The
concentrations of NE, DA, the DA metabolite
3,4-dihydroxyphenylacetic acid (DOPAC),
and the serotonin metabolite 5-hydroxyindole
acetic acid (5-HIAA) were measured as
described previously (MohanKumar et al.
1994, 1998). Brieﬂy, the HPLC-EC appara-
tus consisted of an LC-10 AT/VP pump
(Shimadzu, Columbia, MD), a phase II 5-µm
ODS reverse-phase C18 column (Pheno-
menex, Torrance, CA), a glassy carbon elec-
trode (Bioanalytical Systems, West Lafayette,
IN), a model CTO-10 AT/VP column oven
(Shimadzu, Columbia, MD) maintained at
37°C, and an LC-4C amperometric detector
(Bioanalytical Systems, West Lafayette, IN).
The data were integrated using a computer
with the Class-VP chromatography Laboratory
Automated Software system (version 4.2;
Shimadzu). 
The mobile phase was made with pyrogen-
free water and contained monochloroacetic
acid (14.14 g/L), sodium hydroxide (4.675 g/L),
octanesulfonic acid disodium salt (0.3 g/L),
EDTA (0.25 g/L), and acetonitrile (3.5%), to
which tetrahydrofuran (1.4%) was added.
The mobile phase was then filtered and
degassed through a Milli-Q puriﬁcation system
(Millipore Co., Bedford, MA) and pumped at
a ﬂow rate of 1.8 mL/min. The range of the
detector was 1 nA full scale, and the potential
of the working electrode was 0.65 V. The
sensitivity of the system was < 1 pg.
Protein determination. Protein concentra-
tions in the homogenates were determined
using the micro-bicinchoninic acid assay
(micro BCA; Pierce, Rockford, IL) and neu-
rotransmitter concentrations were expressed
as picograms per microgram protein.
Radioimmunoassay. Double-antibody
radioimmunoassay was used to measure corti-
costerone levels in the serum as described pre-
viously (Francis et al. 2000). Corticosterone
standards and the I125-labeled corticosterone
were obtained from Diagnostic Products Inc.
(Los Angeles, CA). The primary and secondary
antibodies were raised in our laboratory and
were used at dilutions of 1:17,500 and
1:11,000 respectively. The sensitivity of the
corticosterone assay was 0.2 ng/mL.
Statistical analysis. The differences in
serum corticosterone levels, neurotransmit-
ters, and their metabolites among the various
treatment groups were analyzed by one-way
analysis of variance followed by post hoc
Fisher’s least signiﬁcant difference test.
Results
Paraventricular nucleus. Exposure to CAPs
alone or after sensitization with OVA produced
signiﬁcant changes in NE concentrations in the
PVN (Figure 1). Exposure to CAPs alone
increased NE concentrations (mean ± SE,
pg/µg protein) by more than 75% (12.45 ±
2.7) compared with animals exposed to air +
saline (7.98 ± 1.3; p < 0.05). Pretreatment with
OVA increased NE levels to 15.84 ± 2.8.
Exposure to CAPs after sensitization with OVA
increased NE concentrations even further
(19.06 ± 3.8) and produced a greater than
2-fold increase in NE levels compared with the
group treated with air + saline. A trend for a
decrease in DA concentrations was observed
after exposure to CAPs, although it was not sta-
tistically signiﬁcant. There was no signiﬁcant
change in the concentrations of 5-HIAA and
DOPAC after exposure to CAPs.
Medial preoptic area. In contrast to the
PVN, CAP exposure resulted in an increase in
the concentrations of DA in the MPA,
whereas the concentrations of NE, 5-HIAA,
and DOPAC remained unchanged (Figure 2).
The concentration of DA in animals exposed
to CAPs (0.68 ± 0.2) or OVA alone (4.51 ±
1.4) was not different from that of the con-
trols treated with air + saline (0.93 ± 0.1).
However, sensitization with OVA before CAP
exposure increased DA levels significantly
(6.58 ± 2.8) compared with those of the con-
trol and the CAPs + saline group (p < 0.05).
Arcuate nucleus. Unlike the PVN and the
MPA, NE levels (mean ± SE, pg/µg protein)
increased in the AN after OVA sensitization
CAPs, stress, and asthma
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Figure 1. Neurotransmitter concentrations in the
PVN after exposure to CAPs with or without pre-
treatment with OVA. Animals treated with either
OVA or saline (n = 8 per group) were sacrificed
24 hr after an 8-hr exposure to CAPs or ﬁltered air.
*p < 0.05 compared with the air + saline group (control).
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Figure 2. Neurotransmitter concentrations in the
MPA after exposure to CAPs with or without pre-
treatment with OVA. Animals treated with either
OVA or saline (n = 8 per group) were sacrificed
24 hr after an 8-hr exposure to CAPs or ﬁltered air.
*p < 0.05 compared with control animals exposed to 
ﬁltered air.
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NE DA DOPAC 5-HIAA(31.68 ± 4.5) compared with the air + saline
controls (14.75 ± 2.4; p < 0.05) but not after
exposure to CAPs alone (19.77 ± 2.9).
Although there was a trend for an increase in
the concentrations of DA, 5-HIAA, and
DOPAC after CAP exposure, these changes
were not statistically signiﬁcant (Figure 3).
Olfactory bulb. Exposure to CAPs with or
without sensitization to OVA and OVA alone
were all capable of increasing NE levels in the
olfactory bulb (Figure 4). NE concentrations
in control rats treated with air + saline were
8.8 ± 0.8 and increased significantly after
exposure to CAPs (14.2 ± 0.8; p < 0.05).
Sensitization with OVA kept NE levels ele-
vated at 16.2 ± 1.8, and the combination of
CAPs and OVA maintained it at the same
level (16.1 ± 1.6). There were no significant
changes in the other neurotransmitters after
CAP exposure in the olfactory bulb.
Monoamines in other areas. There were
no differences in the levels of monoamines in
other areas of the hypothalamus: the SCN,
median eminence, ventromedial hypothala-
mus, or dorsomedial hypothalamus. Similarly,
the SN and the cortex did not show any sig-
nificant differences in neurotransmitter con-
centrations (Table 1).
Serum corticosterone levels. Levels of corti-
costerone in the serum (mean ± SE, ng/mL;
Figure 5) paralleled the levels of NE in the
PVN. Exposure to CAPs alone (114.55 ±
20.9) or after sensitization with OVA
(242.786 ± 33.315) or exposure to OVA by
itself (294.04 ± 26.228) produced signiﬁcant
increases in serum corticosterone compared
with those in the control group exposed to ﬁl-
tered air (56.096 ± 10.2; p < 0.05). Moreover,
exposure to CAPs after OVA sensitization, and
presensitization with OVA increased serum
corticosterone levels significantly compared
with exposure to CAPs alone (p < 0.05).
Discussion
The results of the present study indicate for the
ﬁrst time that exposure to CAPs can affect the
concentrations of neurotransmitters in speciﬁc
areas of the brain. Changes in neurotransmit-
ters were observed in the olfactory bulb and
discrete areas of the hypothalamus, such as the
PVN, AN, and MPA. Neurotransmitter con-
centrations in other areas of the hypothala-
mus and the brain remained unchanged,
indicating that the effects of CAPs are highly
speciﬁc. Exposure to CAPs also increased cir-
culating levels of corticosterone, paralleling
the increase in NE levels in the PVN, indi-
cating an activation of the hypothalamo–
pituitary–adrenal axis or stress axis. Challenge
with OVA alone produced a marked increase
in stress axis activity that indicated this may
be a homeostatic response to suppress inﬂam-
mation. However, when OVA-sensitized ani-
mals were exposed to CAPs, stress axis activity
remained elevated but no additive effect was
observed. This could indicate that both OVA
and CAPs act through common pathways to
stimulate the stress axis.
In the present study, exposure to CAPs or
OVA sensitization did not produce any change
in the whole hypothalamus (data not shown).
However, marked changes were observed in
speciﬁc nuclei of the hypothalamus that regu-
late various neuroendocrine functions such as
feeding, reproduction, stress, and circadian
activity. Among these, the activation of the
stress axis that was observed in this study is the
most striking. This response could be poten-
tially mediated through the hypothalamus.
The PVN of the hypothalamus accounts for
the highest concentration of corticotrophin-
releasing hormone (CRH) perikarya and can
effect adrenocorticotrophic hormone (ACTH)
release from the pituitary upon stimulation
(Szafarczyk et al. 1987). A number of neuro-
transmitters are known to influence CRH
secretion (Muller and Nistico 1988). Among
these, NE is believed to play a prominent role.
The PVN receives rich noradrenergic innerva-
tion from the brainstem, and neurotoxic block-
ade of its noradrenergic input decreases ACTH
secretion (Szafarczyk et al. 1987, 1988).
Moreover, direct administration of NE into
the PVN also results in an activation of the
stress axis (Itoi et al. 1994). On the contrary,
noradrenergic antagonists have blocked stress
axis activation, emphasizing the importance of
this neurotransmitter in stimulating CRH neu-
rons (Muller and Nistico 1988). In this study,
exposure to CAPs alone resulted in a robust
increase in NE levels in the PVN. A similar
response was observed in OVA-sensitized ani-
mals, indicating that OVA by itself can activate
the stress axis. This effect was accompanied by
elevated corticosterone levels in animals
Sirivelu et al.
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Figure 3. Neurotransmitter concentrations in the
AN after exposure to CAPs with or without pre-
treatment with OVA. Animals treated with either
OVA or saline (n = 8 per group) were sacrificed
24 hr after an 8-hr exposure to CAPs or ﬁltered air.
*p < 0.05 compared with the air + saline group (control).
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Figure 4. Neurotransmitter concentrations in the
olfactory bulb after exposure to CAPs with or without
pretreatment with OVA. Animals treated with either
OVA or saline (n = 8 per group) were sacriﬁced 24 hr
after an 8-hr exposure to CAPs or ﬁltered air.
*p < 0.05 compared with respective controls.
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Table 1. Neurotransmitter concentrations (mean ± SE, pg/µg protein) in discrete brain nuclei after exposure
to CAPs.
Area Treatment NE DA DOPAC 5-HIAA
Median eminence Air + saline 36.04 ± 8.1 44.79 ± 13.8 17.49 ± 5.0 3.75 ± 0.5
CAPs + saline 34.43 ± 6.4 63.09 ± 27.6 18.76 ± 6.1 3.05 ± 0.7
Air + OVA 35.40 ± 6.9 23.76 ± 2.4 6.08 ± 2.2 5.41 ± 0.8
CAPs + OVA 24.23 ± 5.5 60.99 ± 16.5 4.15 ± 1.1 3.82 ± 0.9
SCN Air + saline 12.42 ± 2.2 1.0 ± 0.3 3.1 ± 0.8 3.27 ± 0.5
CAPs + saline 15.92 ± 3.1 1.2 ± 0.5 4.62 ± 0.6 5.82 ± 0.6
Air + OVA 15.18 ± 1.2 1.3 ± 0.4 4.26 ± 0.7 6.04 ± 1.3
CAPs + OVA 19.89 ± 3.5 2.5 ± 0.9 3.56 ± 0.7 4.29 ± 0.6
Ventromedial Air + saline 11.86 ± 2.8 1.63 ± 0.8 2.11 ± 0.4 4.53 ± 0.6
hypothalamus CAPs + saline 21.89 ± 2.3 1.64 ± 0.7 2.45 ± 0.4 4.83 ± 0.2
Air + OVA 25.86 ± 4.5 1.02 ± 0.1 3.27 ± 0.6 4.80 ± 0.4
CAPs + OVA 20.99 ± 3.0 2.02 ± 0.4 2.89 ± 0.3 5.19 ± 1.1
Dorsomedial Air + saline 13.89 ± 2.4 1.35 ± 0.5 2.26 ± 0.6 5.32 ± 0.8
hypothalamus CAPs + saline 13.38 ± 2.7 1.66 ± 0.7 2.16 ± 0.4 5.31 ± 0.4
Air + OVA 13.12 ± 2.7 1.16 ± 0.2 2.39 ± 0.4 6.00 ± 0.5
CAPs + OVA 15.47 ± 3.5  1.84 ± 0.4 2.03 ± 0.3 6.10 ± 0.6
SN  Air + saline 3.08 ± 0.5 2.24 ± 0.7 1.42 ± 0.1 5.02 ± 0.5
CAPs + saline 4.99 ± 0.7 2.24 ± 1.0 2.30 ± 0.4 5.21 ± 0.8
Air + OVA 5.15 ± 0.8 2.35 ± 0.3 2.70 ± 0.4 6.18 ± 0.5
CAPs + OVA 4.71 ± 0.7  2.73 ± 0.7 2.47 ± 0.4 5.85 ± 0.5
Cortex  Air + saline 2.32 ± 0.3 0.27 ± 0.1 0.99 ± 0.1 3.02 ± 0.3
CAPs + saline 1.86 ± 0.3 0.39 ± 0.2 1.36 ± 0.6 2.91 ± 0.4
Air + OVA 2.06 ± 0.2 0.47 ± 0.3 1.60 ± 0.7 3.14 ± 0.3
CAPs + OVA  1.89 ± 0.2 0.84 ± 0.4 2.23 ± 0.8 2.83 ± 0.2
Animals were treated with either OVA or saline (n = 8 per group) and sacriﬁced 24 hr after an 8-hr exposure to CAPs or
ﬁltered air.exposed to CAPs alone or a combination of
CAPs and OVA treatment. Both NE levels in
the PVN and serum corticosterone were high
even in the OVA-sensitized animals upon
exposure to ﬁltered air. This observation is sup-
ported by another study in which sensitization
with OVA alone activates the PVN and the
central nucleus of the amygdala, another
important nucleus in the stress circuitry
(Costa-Pinto et al. 2005). These ﬁndings sug-
gest that the stress axis is activated by immune
challenge/allergic airway disease and that expo-
sure to CAPs also contributes to this effect.
Our present observations indicate that
NE levels are elevated in the AN as well.
Noradrenergic innervation to the AN may also
be involved in the stress axis. We have previ-
ously shown that NE levels in the AN are ele-
vated after an immune stressor such as
(MohanKumar et al. 1998). AN has also been
implicated in autonomic functions such as
IL-1 respiratory processing mediated by
carotid body receptor (Banks and Harris
1988), suggesting that apart from the PVN,
the AN also may be involved in stress-induced
autonomic alterations.
Our previous studies involving chronic
activation of the stress axis with a TH1
cytokine such as IL-1β for a period of 5 days
indicate that NE levels in the PVN stabilize at
the end of the treatment period and are not
significantly different from the controls
(MohanKumar et al. 2003). However, in the
present study, although the animals were
repeatedly exposed to OVA for 3 days, we still
observed an increase in stress axis activity. This
could be because OVA induces a predomi-
nantly eosinophilic response that produces a
TH2-type immune response with increases in
IL-4, IL-5, IL-10, and IL-13 (Erin et al. 2005;
Kalomenidis et al. 2005). Unlike TH1
cytokines that directly affect the stress axis,
TH2 cytokines, especially IL-4 and IL-13, are
involved in the isotype switching from IgM to
IgE, which is the antibody responsible for the
generation of classical allergic reactions
(Marshall 2004). However, in this study we
observed an increase in stress axis activity with
OVA alone. This may indicate a role for TH2
cytokines in stress axis stimulation, a possi-
bility that warrants further investigation.
Therefore, the nature, duration, and intensity
of a speciﬁc immune response and its effect on
the stress axis may depend on a delicate bal-
ance between these two classes of cytokines
(Marshall 2004).
The activation of the stress axis after CAP
exposure or OVA sensitization could be a
homeostatic mechanism to counter the inﬂam-
matory response elicited by these paradigms.
One of the mechanisms by which homeostasis
is achieved could be by facilitating the elimina-
tion of tissue eosinophils through the airway
lumen (Uller et al. 2006). On the other hand,
corticosterone could cause a shift in the
TH1/TH2 response, increasing the production
of IL-4 and IL-13 that could increase the secre-
tions in airways promoting allergic airway dis-
eases (Erin et al. 2005; Marshall 2004).
CAP exposure has produced a marked ele-
vation in DA concentrations in the MPA. The
present study was conducted using male rats,
and in males, DA in the MPA is involved in
sexual motivation and copulatory behavior
(Bitran et al. 1988; Pehek et al. 1988).
Moreover, the MPA receives chemosensory
stimuli from the olfactory bulb (Murphy and
Schneider 1970), and these inputs have been
implied to be obligatory for the increase in
DA in the MPA during copulation (Triemstra
et al. 2005). The increase in DA observed in
the MPA in this study could therefore be a
result of olfactory stimulation.
The olfactory bulb has been implicated in
the neuroendocrine control of various auto-
nomic activities. Stimulation of the olfactory
bulb by several methods, including smoke
exposure, has resulted in altered cardiovascular
and respiratory parameters and increased sym-
pathetic activity (Nakamura and Hayashida
1992). The olfactory bulb has connections to
noradrenergic neurons of the brainstem
(Cassell and Roberts 1991; Perez et al. 1987),
especially those located in the nucleus of the
solitary tract (NTS; A2 cell group) and the
locus coeruleus (A6 cell group). Besides inner-
vating the PVN, the NTS is also involved in
the critical regulation of respiration (Haxhiu
et al. 2005). In the NTS, a down-regulation of
GABAergic inhibitory inﬂuences may lead to
heightened airway responsiveness and sus-
tained narrowing of the airways (Haxhiu et al.
2005). Because GABA (γ-aminobutyric acid)
and NE are known to have a reciprocal rela-
tionship in most central functions (Muller and
Nistico 1988), it is possible that the observed
increase in noradrenergic activity in the olfac-
tory bulb is related to a reduction in GABA
levels, and this could translate into an altered
respiratory response with the NTS as a possi-
ble relay center. Alternatively, neurons of the
olfactory tract extend to the amygdala, which
sends fibers to the lateral hypothalamus and
the NTS besides other areas (Price 2003).
This could be another potential pathway by
which the olfactory lobe can affect respiration.
However, further studies are needed to investi-
gate the interconnection between the olfactory
bulb and brainstem noradrenergic neurons in
precipitating respiratory effects as a result of
CAP exposure.
The mechanism by which CAP exposure
leads to changes in neurotransmitters in the
brain is unclear. The constituents and compo-
sition of the PM may be one important factor
to be considered in understanding potential
mechanisms. Nitric oxide, a component of
PM2.5, can inﬂuence neurotransmitter systems
(Rettori et al. 1992). Ultrafine particles in
CAPs can translocate from the nasal cavity to
the olfactory bulb, most likely through olfac-
tory nerves (Oberdorster et al. 2004), where
they may incite a foreign-body reaction, acti-
vating glial cells to release reactive oxygen
species (Block et al. 2004; Veronesi et al.
2005). In fact, exposure to CAPs is known to
increase the levels of nuclear factor κB in the
brains of dogs indicating early inflammatory
changes (Calderon-Garciduenas et al. 2003).
It has been shown previously that lipopolysac-
charide (LPS) is a constituent of CAPs as well
as OVA, which was used for sensitization
(Campbell et al. 2005). The same study
demonstrated an increase in inflammatory
cytokines, IL-1α, and tumor necrosis factor-α
(TNF-α) in the brain upon exposure to CAPs.
However the concentrations of LPS found
were too low to stimulate IL-1 production,
and the ability of LPS at these levels to stimu-
late IL-1 production remains questionable.
LPS is shown to mediate neuroendocrine
changes in the hypothalamus through IL-1
(MohanKumar et al. 1999) as well as TNF-α
(Turnbull and Rivier 1998). IL-1 has been
shown to produce elevations of NE in the
PVN and AN (MohanKumar and Quadri
1993; MohanKumar et al. 1998) as well as
elevation of ACTH and corticosterone levels
(Lacosta et al. 1998). Besides increasing brain
IL-1, inhaled CAPs may affect the pulmonary
epithelium to cause inflammation and an
increase in circulating cytokines. An increase
in peripheral cytokines may also have a direct
effect on brain NE levels (MohanKumar and
Quadri 1993). It is possible that the activation
of the stress axis by CAPs may be mediated at
least in part through elevated cytokine levels.
Thus, the present study demonstrates for
the ﬁrst time that exposure to CAPs containing
PM2.5 produces changes in neurotransmitter
levels in speciﬁc areas of the brain and modu-
lates neuroendocrine pathways involved in the
stress axis and the autonomic control of respi-
ratory functions. This could be one of the
potential modes by which CAPs could affect
the neuroendocrine and autonomic systems.
CAPs, stress, and asthma
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Figure 5. Serum corticosterone concentrations
after exposure to CAPs with or without pretreat-
ment with OVA. Animals treated with either OVA or
saline (n = 8 per group) were sacriﬁced 24 hr after
an 8-hr exposure to CAPs or ﬁltered air. 
*p < 0.05 compared with the air + saline group. **p < 0.05
compared with the CAPs + saline group.
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